Informatie:
Fout:
ID
34405
Beschrijving
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00941720
Link
https://clinicaltrials.gov/show/NCT00941720
Trefwoorden
Versies (1)
- 17-01-19 17-01-19 -
Houder van rechten
GSK group of companies
Geüploaded op
17 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients with a diagnosis of plasma cell myeloma
boolean
ID.2
Item
patients with cardiac ejection fraction >= 45% or clearance by cleveland clinic faculty (ccf) cardiologist
boolean
ID.3
Item
patients with diffusion capacity of carbon monoxide (dlco) >= 45% predicted or clearance by ccf pulmonologist
boolean
ID.4
Item
patient with previously harvested peripheral blood progenitor cells with a minimum of 2 x 10^6 cd 34+ cells/kg harvested
boolean
ID.5
Item
patients receiving total body irradiation
boolean
ID.6
Item
non-myeloablative/reduced-intensity conditioning
boolean
ID.7
Item
pregnant and breast feeding patients
boolean
ID.8
Item
human immunodeficiency virus (hiv) positive
boolean
ID.9
Item
patients with serum creatinine > 2.0
boolean
ID.10
Item
prior hematopoietic stem cell (hsc) transplant
boolean